Pharmaceutical fraud encompasses a variety of illegal schemes utilized by pharmaceutical manufacturers, pharmacies, or other health care providers resulting in the submission of claims for reimbursement from government programs for drugs that are improperly manufactured, marketed, or priced.
Kenney & McCafferty has been representing tax whistleblowers in complex tax fraud schemes for well over 10 years. In doing so, Kenney & McCafferty attorneys obtained numerous rewards for our clients and have restored over $100 million to the United States Treasury. Oftentimes, whistleblowers who are aware of a False Claims Act violation may not realize that they also may be entitled to a reward under the IRS Whistleblower Law. If a whistleblower has a viable claim under the IRS Whistleblower Law in addition to an FCA claim, the two claims would be filed separately, and the filing of one claim would not preclude the filing of the other.
To qualify for a reward under the IRS Whistleblower Program, your disclosure must present concrete, detailed evidence of tax fraud or tax underpayment. Speculative disclosures lacking specific, documented evidence will not earn a reward. Under the IRS Whistleblower Law, whistleblowers are entitled to 15-30% of the civil taxes, penalties and interest collected by the IRS.